WHWK

Whitehawk Therapeutics Inc NASDAQ Listed Aug 1, 2017

Healthcare ·Biotechnology ·US · ir.whitehawktx.com

$3.94

Mkt Cap $194.7M

52w Low $1.55 81.6% of range 52w High $4.48

50d MA $3.76 200d MA $2.63

P/E (TTM) -12.1x

EV/EBITDA -1.0x

P/B 1.8x

Debt/Equity 0.0x

ROE -15.1%

P/FCF -1.5x

RSI (14) —

ATR (14) —

Beta 0.62

50d MA $3.76

200d MA $2.63

Avg Volume 185.1K

Whitehawk Therapeutics Inc operates as a clinical-stage biopharmaceutical company. The Company develops precision therapies for genetically-defined cancers.

SIC Code

2834

CIK (SEC)

1422142

Phone

551 321 2234

17383 Sunset Blvd, Suite A250 · Pacific Palisades, CA 90272 · US

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
May 7, 2026	BMO	—	—	—	4.15	-0.2%	-5.1%	+0.8%	—	—	—	—
Mar 12, 2026	AMC	-0.55	-0.34	+38.2%	3.90	+0.3%	+0.3%	-0.3%	+1.3%	-3.5%	-5.8%	—
Nov 6, 2025	AMC	-0.51	-0.26	+49.0%	2.10	+0.0%	-1.4%	+5.3%	+2.3%	+0.0%	-6.3%	—
Aug 7, 2025	AMC	0.49	-0.76	-255.1%	1.72	+0.0%	+1.7%	-3.4%	+1.2%	+0.0%	-5.3%	—
May 8, 2025	AMC	-0.46	-0.36	+21.7%	1.64	+6.1%	+3.7%	-1.8%	-1.2%	+1.8%	+0.6%	—
Mar 18, 2025	AMC	-0.22	-0.67	-204.5%	2.05	-13.7%	-1.5%	-3.0%	+4.6%	-3.4%	-1.5%	—

Data updated apr 27, 2026 9:21am · Source: massive.com